Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children

Journal of Pediatrics

Volumn 142, Issue 2, 2003, Pages 185-190

  Bortolotti, Flavia ^a   Muratori, Luigi ^b   Jara, Paloma ^b   Hierro, Loreto ^b   Verucchi, Gabriella ^b   Giacchino, Raffaella ^b   Barbera, Cristiana ^b   Zancan, Lucia ^b   Guido, Maria ^b   Resti, Massimo ^b   Pedditzi, Sabrina ^b   Bianchi, Francesco ^b   Gatta, Angelo ^b  

^a Policlinico Universitario   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AUTOANTIBODY; AZATHIOPRINE; CYTOCHROME P450 2D6; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LKM1 AUTOANTIBODY; MICROSOME ANTIBODY; PREDNISONE; RECOMBINANT ALPHA INTERFERON; STEROID; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL RESEARCH; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; KIDNEY MICROSOME; LIVER INJURY; LIVER MICROSOME; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; VIRUS INFECTION;

EID: 0037328932     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2003.45     Document Type: Article

References (38)

1. Lunel F, Abuaf N, Frangeuil L, Grippon P, Perrin M, Le Coz Y, et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992;16:630-6.
2. Pawlotsky J-M, Roudot-Thoraval F, Simmonds P, Mellors J, Ben Yahia M, Andre C, et al. Extrahepatic immunologic manifestations in chronic hepatitits C and hepatitis C serotypes. Ann Intern Med 1995;122:169-73.
3. Michitaka K, Durazzo M, Tillmann HL, Walker D, Philipp T, Manns MP. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology 1994;106:1603-10.
4. Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuroniltransferases: model autoantigens to study drug-induced, virus-induced and autoimmune liver disease. Hepatology 1997;26:1054-66.
5. Karlsen AE, Dyrberg T. Molecular mimicry between non-self, modified self and self in autoimmunity. Semin Immunol 1998;10:25-32.
6. Bortolotti F, Vajro P, Balli F, Giacchino R, Crivellaro C, Barbera C, et al. Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol 1996;25:614-20.
7. Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli Vergani G, Vergani D. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998;112:471-6.
8. Maggiore G, Bernard O, Homberg JC, Hadchouel M, Alvarez F, Hadchouel P, et al. Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr 1985;108:399-404.
9. Abuaf N, Lunel F, Giral P, Borotto E, Laperche S, Poupon R, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993;18:359-64.
10. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-7.
11. Bianchi FB, Cassani F, Lenzi M, Ballardini G, Muratori G, Giostra F, et. al. Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis: an Italian experience. Dig Dis Sci 1996;41:166-71.
12. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 auto-antibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 mono-oxygenase. J Clin Invest 1991;88:1370-8.
13. Yamamoto AM, Creteuil D, Homberg JC, Alvarez F. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology 1993;104:1762-7.
14. Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli Vergani G, Vergani D, et al. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 1995;37:406-12.
15. Perez N, Herzog D, Jaquz-Aigrain E, Homberg JC, Alvarez F. Study of the B cell response to cytochrome P450II in sera from chronic hepatitis C patients. Clin Exp Immunol 1996;106:336-43.
16. Ma Y, Gregorio G, Gaken J, Muratori L, Bianchi FB, Mieli Vergani G, et al. Establishment of a novel radio-ligand assay using eucaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection. J Hepatol 1997;26:1936-42.
17. Yamamoto AM, Johanet C, Duclos-Vallée JC, Bustarret FA, Alvarez F, Homberg JC, et al. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type 2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay. Clin Exp Immunol 1997;108:396-400.
18. Klein R, Zanger M, Berg T, Hopf U, Berg PA. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol 1999;118:290-97.
19. Muratori L, Parola M, Ripalti A, Robino G, Muratori P, Bellomo G, et al. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 2000;46:553-61.
20. Czaja AJ, Manns M, Homburger HA. Frequency and significance of antibodies to Liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992;103:1290-5.
21. McFarlane IG. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 1998;42:599-602.
22. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-6.
23. Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, et al. Prevalence of non-organ specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 1999;45:435-41.
24. Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, et al. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 1994;21:199-03.
25. Duclos-Vallée JC, Nishioka M, Hosomi N, Arima K, Leclerqu A, Bach JF, et al. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by quantitative radioligand assay for CYP2D6 antibody detection. J Hepatol 1998;28:965-70.
26. Ijima Y, Kato T, Miyakawa H, Ogino M, Mizuno M, Sugihara K, et al. Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome antibody type 1. J Gastroenterol Hepatol 2001;16:782-8.
27. Todros L, Saracco G, Durazzo M, Abate ML, Touscoz G, Scaglione L, et al. Efficacy and safety of interferon alpha therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology 1995;22:1374-8.
28. Jara P, Resti M, Zancan L, Giacchino, Hierro L, Sokal E, et al. Natural history of chronic HCV infection in children. J Hepatol 1999;30(suppl 1):52.
29. Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, et al. Recombinant interferon-alpha therapy in children with chronic hepatitis C. Hepatology 1995;22:1623-6.
30. Jara P, Hierro E, Frauca MJ, Robledo C, Camarena C, De La Vega A, et al. Interferon alfa-2b in children with chronic HCV hepatitis. Proceedings of the 30th Annual Meeting of ESPGHAN, Tessaloniki 1997. p. 65.
31. Shiff ER, De Medina M, Kahn RS. New perspectives in the diagnosis of hepatitis C. Semin Liver Dis 1999;19(suppl 1):3-15.
32. Muratori L, Cataleta M, Muratori P, Manotti P, Lenzi M, Cassani F, et al. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques. J Immunol Methods 1995;187:259-64.
33. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Goudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
34. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
35. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990;335:754-7.
36. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 1995;108:157-64.
37. Jurado A, Cardaba B, Jara P, Cuadrado P, Hierro L, de Andres B, et al. Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. J Hepatol 1997;26:983-91.
38. Iorio R, Giannattasio A, Vespere G, Vegnente A. LKM1 antibody and interferon therapy in children with chronic hepatitis C. J Hepatol 2001;35:685-7.